Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Series/ Type

Series/type

Search tool

Displaying 1 - 20 of 51

Publications

Drug-related health and security threats in the Western Balkans

21.11.2022

This report presents a comprehensive analysis of the drug situation in the Western Balkans focused on health and security aspects. It provides a holistic and strategically oriented understanding of the drug situation by bringing together the available information on drug policies and interventions...

Publications

Frequently asked questions (FAQ): drug overdose deaths in Europe (topic overview)

31.08.2022

These pages provide an update on drug-related deaths in Europe, presenting and analysing the latest data on and trends in drug-induced deaths in the European Union, Norway and Turkey. They draw on contributions from specialists from these countries, as well as on information provided by European...

Publications

European Web Survey on Drugs 2021: Emerging findings in Lebanon

21.07.2022

The European Web Survey on Drugs collected data during March and May 2021 from people who use drugs, are aged 18 or older, and live in 21 EU and 9 non-EU countries including Lebanon. In this period, the populations in many European and neighbouring countries were experiencing COVID-19-related...

Publications

European Web Survey on Drugs 2021: Emerging findings in Georgia

21.07.2022

The European Web Survey on Drugs collected data during March to May 2021 from people who use drugs, are aged 18 or older and live in Georgia. In this period, the populations in many European and neighbouring countries were experiencing COVID-19-related lockdown or restrictions. Unless otherwise...

Publications

European Drug Report 2022: Trends and Developments

14.06.2022

The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions.

Publications

Penalties for drug law offences in Europe at a glance

26.04.2022

This tool lets you examine and compare the penalties or rehabilitative responses for the core offences of drug use, possession for personal use, and supply-related offences, across countries in Europe. It also allows you to see how the laws vary those penalties according to the type or quantity of...

Publications

Opioids: health and social responses

21.10.2021

This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide 2021. The guide supports practitioners and policymakers in tackling the negative consequences of drug use. Particularly, the opioids miniguide provides an overview of the...

Publications

Prison and drugs in Europe: current and future challenges

25.06.2021

This publication provides an overview of current knowledge and the latest developments in the field of drug use and prison in Europe. The report explores in depth the epidemiology of drug use and drug-related problems among the prison population, the available social and health service responses to...

Publications

European Drug Report 2021: Trends and Developments

09.06.2021

The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm reduction interventions.

Publications

Drug-related deaths and mortality in Europe: update from the EMCDDA expert network

11.05.2021

This report provides an update on drug-related deaths in Europe based primarily on presentations and discussions held at the 2019 meeting of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) expert network on drug-related deaths. The meeting brought together experts and...

Publications

Impact of COVID-19 on drug markets, use, harms and drug services in the community and prisons

30.04.2021

Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and drug markets have been impacted, as have the services...

Publications

An analysis of drugs in used syringes from sentinel European cities: results from the ESCAPE project, 2018 and 2019

17.02.2021

This report presents new findings from the ESCAPE (European Syringe Collection and Analysis Project Enterprise) network, based on the chemical analysis of the contents of used syringes across sentinel sites in Europe. Syringes were collected in 2018 and 2019 from the bins of street automatic...

Publications

Balancing access to opioid substitution treatment (OST) with preventing the diversion of opioid substitution medications in Europe: challenges and implications

10.02.2021

This report reviews how opioid substitution treatment (OST) is implemented in European countries and examines the public health consequences of the diversion and misuse of prescription OST medications. It looks at how OST medications are diverted to the illicit market, the motivations behind...

Publications

European Drug Report 2020: Key Issues

22.09.2020

This report, available in 24 languages, presents a summary of some the main findings of the 'European Drug Report 2020: Trends and Developments the EMCDDA’s latest analysis of the drug situation in Europe. The issues selected here have been chosen for their policy relevance and general interest.

Publications

EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europe

23.06.2020

Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this pandemic for people who use drugs in Europe, the EMCDDA instigated a mixed-...

Publications

EU Drug Markets — Impact of COVID-19

29.05.2020

What effect is COVID-19 having on the drug market in the EU? This joint publication from the EMCDDA and Europol analyses the impact of the pandemic on the market for the main drug types (cannabis, heroin, cocaine, amphetamines, NPS), including demand, production, trafficking and availability. It...

Publications

EMCDDA trendspotter briefing - Impact of COVID-19 on drug services and help-seeking in Europe

12.05.2020

Since the start of 2020, European countries have been experiencing an unprecedented public health threat with the emergence of the coronavirus disease (COVID-19). In order to investigate the effects and implications of this outbreak for drug services in Europe, the European Monitoring Centre for...

Publications

EU Drug Markets Report 2019

27.11.2019

The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. A more recent version of this publication is now available: EU Drug Markets: In-depth analysis The analysis presented in this report spans numerous topics...

Publications

Highlights from the EU Drug Markets Report for policy and practice

26.11.2019

This short publication presents the main highlights from the EU Drug Markets Report 2019, targeting policy and practice.

Publications

Using open-source information to improve the European drug monitoring system

26.11.2019

This paper explains the methodology developed by the EMCDDA for open-source information monitoring in the area of drug markets. Initially designed to support the work of the EU Early Warning System in 2016, the technique has recently been expanded to cover open-source information through a pilot...
Loading